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Background: Previous studies of nonclinical samples 
exhibiting schizotypal traits have provided support for 
the existence of a continuous distribution of psychotic 
symptoms in the general population. Few studies, how-
ever, have examined the neural correlates of psychometric 
schizotypy using structural and diffusion tensor imaging 
(DTI).  Methods: Healthy volunteers between the ages 
of 18 and 68 were recruited from the community and 
assessed using the Schizotypal Personality Questionnaire 
and received structural and DTI exams. Participants with 
high (N = 67) and low (N = 71) psychometric schizotypy 
were compared on gray and white matter volume, and cor-
tical thickness in frontal and temporal lobe regions and on 
fractional anisotropy (FA) within 5 association tracts tra-
versing the frontal and temporal lobes.  Results: Higher 
levels of schizotypy were associated with lower overall 
volumes of gray matter in both the frontal and temporal 
lobes and lower gray matter thickness in the temporal 
lobe. Regionally specific effects were evident in both white 
matter and gray matter volume of the rostral middle fron-
tal cortex and gray matter volume in the pars orbitalis. 
Moreover, relative to individuals who scored low, those 
who scored high in schizotypy had lower FA in the inferior 
fronto-occipital fasciculus as well as greater asymmetry 
(right > left) in the uncinate fasciculus.  Conclusions: 
These findings are broadly consistent with recent data on 
the neurobiological correlates of psychometric schizotypy 
as well as findings in schizotypal personality disorder and 
schizophrenia and suggest that frontotemporal lobe dys-
function may represent a core component of the psychosis 
phenotype.
Key words:  schizotypy/MRI/DTI/healthy subjects
Introduction
Large-scale genome-wide association studies1,2 have pro-
vided strong evidence that the etiology of schizophrenia 
(SZ) is complex and multifactorial. Moreover, such stud-
ies have demonstrated that hundreds to thousands of 
common genetic variants with small effects contribute to 
the behavioral expression of psychotic-like phenomena 
across traditional diagnostic boundaries.3 Such findings 
provide strong support for a dimensional model in which 
phenomenological, genetic, and cognitive factors inter-
act to affect the behavioral expression and severity of 
psychotic symptoms.4 At the phenotypic level, evidence 
suggests the existence of a continuous distribution of psy-
chotic symptoms in the general population ranging from 
mild, or subclinical, to severe and clinically significant, 
with additional evidence indicating etiological continuity 
between subclinical and clinically significant psychosis 
phenotypes.5 The continuity between subclinical psycho-
sis at the population level and the clinically significant 
levels of psychosis observed in SZ spectrum disorders 
may provide a unique opportunity to elucidate the patho-
physiology of psychotic disorders free of the potentially 
confounding effects of treatment-related factors.
Although several approaches have been employed to 
measure subclinical psychosis in nontreatment seeking 
populations, the measurement of schizotypal traits is 
among the most common.6 Schizotypy was initially con-
ceptualized by Rado7, and later elaborated by Meehl8,9, 
to denote the genetically determined predisposition to 
SZ and may be measured in nonclinical samples using 
psychometric self-report questionnaires such as the 
Schizotypal Personality Questionnaire (SPQ)10 or the 
Chapman Scales.11 Studies have generally demonstrated 
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schizotypy to have dimensional factor structures analo-
gous to those observed in SZ.12–14 Moreover, several inde-
pendent studies15–18 have shown an increased incidence 
of schizotypy in relatives of SZ patients that are likely 
related to shared genetic variation.19,20 Thus, the exami-
nation of psychometric schizotypy within nonpsychiatric 
populations is ideally suited for studies seeking to better 
characterize the neurobiology of psychosis.21
Several studies have examined the neurobiological 
basis of schizotypal personality disorder (SPD), a disor-
der characterized by severe schizotypal traits including 
asocial tendencies, difficulties with language, paranoia, 
odd behavior, and magical thinking. Recent reviews22–24 
suggest that at the structural level, SPD is associated 
with temporal lobe abnormalities comparable to those 
observed in SZ while frontal lobe regions may be more 
spared. Moreover, the aforementioned reviews also sug-
gest that low fractional anisotropy (FA), a measure 
broadly associated with white matter integrity, in the unci-
nate fasciculus (UF) and temporal lobe is present in SPD; 
a finding generally consistent with those observed in SZ.25 
To date, however, relatively few studies have examined the 
neurobiological basis of psychometric schizotypy, or sub-
clinical psychosis, in otherwise healthy adults.
Although several studies have reported structural dif-
ferences between healthy participants with high levels of 
subclinical positive symptoms vs low levels, overall find-
ings have been mixed.26–28 However, several studies have 
reported cortical thickness abnormalities among healthy 
individuals with high levels of schizotypy compared with 
low levels29,30 that are broadly consistent with findings in 
SZ patient samples.31 Additionally, diffusion tensor imag-
ing (DTI) studies have provided complementary evidence 
for white matter alterations in psychometrically defined 
schizotypy similar to those observed in SZ, but these 
findings have also been inconsistent. While some studies 
have found higher FA in some regions but lower FA in 
others,32 others have found consistent reductions in FA in 
several regions33,34 and yet others have found increases in 
FA35 related to high levels of subclinical psychotic symp-
toms. Taken together these studies implicate aberrant 
neurodevelopmental processes in subclinical psychosis 
that are similar to those believed to underlie the neurobi-
ology of SZ without the associated confound of antipsy-
chotic medications and suggest that the examination of 
psychometric schizotypy in nonpsychiatric populations 
may provide insight into the neurobiology of psychosis. 
Samples examined in prior work, however, have been rel-
atively small and have not comprehensively assessed the 
brain using multimodal imaging. Moreover, several prior 
studies examined adolescent and young adult samples 
that may still be at risk for developing psychosis. In the 
present study, we thus investigated both gray and white 
matter structural variation in relation to psychometric 
schizotypy using structural and DTI in a large sample of 
healthy adults. Consistent with observations of less gray 
matter volume in SZ36 and with models of frontotem-
poral lobe dysfunction in SZ,37–39 we hypothesized that 
individuals characterized by high schizotypy would dem-
onstrate less gray matter volume, lower cortical thickness, 
and lower FA in frontal and temporal lobe regions, com-
pared with those characterized by low schizotypy.
Methods
Participants
The present sample comprised 138 (72 M/66 F) healthy vol-
unteers ages 18–68 (Meanage = 35.69 ± 13.02). Participants 
were recruited from the general population via word 
of mouth, newspaper and internet advertisements, and 
posted fliers for an National Institute of Mental Health-
funded study of subclinical psychosis (MH086756 to 
P.D.). Participation in the imaging component of the study 
was optional. A  total of 38 additional participants were 
screened for participation in the present study but were not 
included because they met one or more exclusion criteria. 
Exclusion criteria included having a first-degree family 
member with a psychotic illness, present or past psychotic 
or affective disorder diagnosis as determined by clinical 
interview using the nonpatient edition of the Structured 
Clinical Interview for the DSM-IV, Non-Patient edition 
(SCIDI-N/P),40 evidence of an intellectual disability (oper-
ationally defined as a Wide Range Achievement Test-Third 
Edition-Reading Subtest [WRAT-3] reading score of <70), 
active or recent substance abuse (as assessed by urine toxi-
cology testing), magnetic resonance imaging (MRI) contra-
indications (eg, pacemaker, internal defibrillator, infusion 
pump, insulin pump, cochlear implant, hearing aid, iron/
steel on or in the body), pregnancy, or significant medical 
illness as determined by a medical history questionnaire. 
This study was approved by the North Shore-Long Island 
Jewish Health System Institutional Review Board and all 
participants provided written, informed consent.
Clinical Assessments
All assessments were conducted by Master’s or PhD level 
clinicians or psychometicians who have extensive training 
in the administration of clinical and cognitive assessments.
Diagnostic Assessments. Participants were initially admin-
istered the SCIDI-N/P40 to rule out a past or present affec-
tive or psychotic disorder. Information obtained from the 
SCID was compiled into a narrative case summary and pre-
sented to 2 senior members of the Zucker Hillside Hospital 
clinical faculty. Absence of pathology was determined by 
consensus after the presentation of the narrative case sum-
mary and discussion of any relevant symptomatology.
Psychometric Schizotypy. To assess schizotypal symp-
tom severity we utilized the SPQ,10 which is a well-val-
idated, 74-item, self-report questionnaire. The SPQ 
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provides an overall measure of psychometric schizotypy 
that includes 9 dimensions, each reflecting a criterion 
for DSM-IV schizotypal personality disorder, including 
ideas of reference, excessive social anxiety, odd beliefs or 
magical thinking, unusual perceptual experiences, odd 
or eccentric behavior, no close friends, odd speech, con-
stricted affect, and suspiciousness.
Estimated IQ. We utilized the WRAT-3 as an estimate 
of IQ. The WRAT-3 is a test that assesses single word 
reading skill and is highly correlated with full scale IQ.41
Handedness. All individuals were classified as either 
right or left-handed based on a modified version of the 
Edinburgh Inventory. The total number of right and left 
hand items was scored and the laterality quotient was 
computed according to the following formula: (Total R − 
Total L)/(Total R + Total L) yielding a range from +1.00 
(totally dextral) to −1.00 (totally nondextral).
Magnetic Resonance Imaging
Image Acquisition. MRI exams were conducted at 
the North Shore University Medical Center on a GE 
3T Signa HDx, whole body superconducting imaging 
system. A  radiologist reviewed all scans for gross ana-
tomic pathology that would preclude participation in 
this study. We minimized movement by stabilizing the 
head with cushions prior to scanning. We acquired 3D 
spoiled gradient images using a 1-mm thick slice acquisi-
tion with the following image parameters: repetition time 
(TR) = 7.5 ms, echo time (TE) = 3 ms, matrix = 256 × 256, 
field of view (FOV)  =  240 mm, 216 contiguous images. 
We also acquired DTI data using a total of 36 DTI vol-
umes from each subject, including 31 volumes with dif-
fusion gradients applied along 31 nonparallel directions 
with b = 1000 s/mm2 and, and 5 volumes without diffu-
sion weighting (b = 0 s/mm2). Each volume consisted of 
51 contiguous 2.5-mm axial slices acquired parallel to 
the anterior-posterior commissural line using a ramp 
sampled, spin-echo, single-shot echoplanar imaging 
method (TR = 1400 ms, TE = min, matrix = 128 × 128, 
FOV = 240 mm).
Structural Imaging Methods. Cortical reconstruc-
tion and volumetric segmentation was performed using 
Freesurfer image analysis software (version 5.0.0), which 
is documented and freely available online (http://surfer.
nmr.mgh.harvard.edu). Technical details of these proce-
dures are described in prior publications.42–44 Processing 
includes motion correction, removal of non-brain tissue,45 
automated Talairach transformation, segmentation of the 
subcortical regions and deep gray matter structures43 inten-
sity normalization,46 tessellation of the gray matter-white 
matter boundary, automated topology correction,47,48 and 
surface deformation following intensity gradients.49 Gray 
matter volume, white matter volume, and cortical thick-
ness measures were computed and subsequently assigned 
to either the frontal or temporal lobes. Individual regions 
comprising the frontal (N = 11) and temporal (N = 9) 
lobes were determined a priori based on prior work.50 The 
frontal lobe included the superior frontal, rostral middle 
frontal, caudal middle frontal, pars opercularis, pars tri-
angularis, pars orbitalis, lateral orbital frontal, medial 
orbital frontal, precentral, paracentral, and frontal pole 
regions. The temporal lobe included the superior tem-
poral, middle temporal, inferior temporal, banks of the 
superior temporal sulcus, fusiform gyrus, transverse tem-
poral, entorhinal, temporal pole, and parahippocampal 
regions. These regions are illustrated in figure 1.
DTI Methods and Tractography. Image processing was 
conducted using the Functional Magnetic Resonance 
Imaging of the Brain Software Library (FSL; http://fsl.
fmrib.ox.ac.uk/fsl/). Eddy-current induced distortions and 
head-motion displacements were corrected through affine 
registration of the 31 diffusion volumes to the first b0 vol-
ume using FSL’s Linear Registration Tool (FLIRT).51 The 
b-vector table (ie, gradient directions) for each participant 
was then adjusted according to the rotation parameters of 
this linear correction. Non-brain tissue was removed using 
FSL’s Brain Extraction Tool. FA was then calculated at 
each voxel of the brain by fitting a diffusion tensor model 
to the raw diffusion data using weighted least squares in 
FSL’s Diffusion Toolbox.
FA within 5 association tracts traversing the frontal 
and temporal lobes were assessed, including the inferior 
fronto-occipital fasciculus (IFOF), inferior longitudinal 
fasciculus (ILF), cingulum bundle, superior longitudinal 
fasciculus (SLF), and UF. These tracts are illustrated in 
figure 2. Detailed delineation criteria regarding the indi-
vidual tracts are provided in our prior study.52 Within-
voxel probability density functions of the principal 
diffusion direction were estimated using Markov Chain 
Monte Carlo sampling in FSL’s BEDPOSTX tool.53 
A spatial probability density function was then estimated 
across voxels based on these local probability density 
functions using FSL’s PROBTRACKX tool,53 in which 
5000 samples were taken for each input voxel with a 0.2 
curvature threshold, 0.5-mm step length, and 2000 steps 
per sample. For each tract, seed masks, way-points, termi-
nation, and exclusion masks were defined on the MNI152 
T1 1-mm template. Masks were normalized to each sub-
jects’ diffusion space using FLIRT,51 applying the affine 
parameters obtained by coregistering the first b0 volume 
to the MNI152 1-mm T1 brain. The resulting tracts were 
thresholded at a normalized probability value.
Statistical Analysis
In all analyses, the distribution of the dependent mea-
sures was first inspected to ensure normality. Although 
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Fig. 2. Five association tracts traversing the frontal and temporal lobes examined in the present study for association to psychometric schizotypy.
Fig. 1. Freesurfer segmentation of fronto-temporal regions examined in the present study for association to psychometric schizotypy.
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we initially considered using the SPQ Total score as a 
continuous measure in regression models, this approach 
was not statistically valid because neither the SPQ scores, 
nor the residuals produced by the regression models, 
were normally distributed. Therefore, we dichotomized 
the sample, using a median split, into those who scored 
higher (high schizotypy: N = 67) and those who scored 
lower (low schizotypy: N = 71) on the SPQ.
Initially, group differences in demographic character-
istics were assessed using independent group’s t tests or 
chi-square tests. Repeated measures ANCOVA was used 
to assess group differences in brain structure volume and 
thickness, and FA within tracts. In brain structure vol-
ume and cortical thickness analyses, group served as the 
between-subjects factor. We summed right and left hemi-
sphere volumes for gray matter and white matter struc-
tures, respectively and averaged right and left cortical 
thickness given the lack of group × hemisphere interac-
tions for these measures. Gray matter volume, white matter 
volume, and cortical thickness served as the within-sub-
jects factors in separate analyses investigating the fron-
tal and temporal lobes. We used the Greenhouse-Geisser 
correction in these analyses given that the Mauchly’s test 
of sphericity was significant. There were significant group 
by hemisphere effects for the FA measures and thus, we 
did not average these measures for subsequent analyses. 
Thus, hemisphere served as a within-subjects factor in FA 
analyses, which were conducted separately by tract given 
their functional and neuroanatomical heterogeneity.52 
In all analyses, age, sex, and intracranial volume were 
included as covariates. Alpha was set to .05 and all analy-
ses were 2 tailed.
Results
Comparison of high vs low schizotypy groups on the 
total SPQ score confirmed that the groups significantly 
differed (MHigh = 8.52 ± 6.66 vs MLow = 0.75 ± 0.82; t = 
9.49; P < .001). Moreover, the relatively low mean of the 
high schizotypy group suggested symptom levels were 
reflective of subclinical psychometric schizotypy rather 
than schizotypal personality disorder. Comparison of 
high and low schizotypy groups on additional demo-
graphic characteristics revealed no significant differences 
(all P’s > .05) in age (MHigh = 36.17 ± 13.93 vs MLow = 
35.23 ± 12.18), estimated IQ (MHigh = 101.91 ± 11.09 vs 
MLow = 101.39 ± 9.80), or handedness (MHigh = 0.77 ± 
0.50 vs MLow=0.80 ± 0.38). Examination of sex distribu-
tions revealed that the proportion of females in the high 
schizotypy group (56.72%) was significantly greater than 
in the low schizotypy group (39.44%) (χ2 = 4.13, P = .04).
Mean (SD) values for the frontal and temporal lobe 
white matter and gray matter volumes are provided in 
table  1 with univariate analyses provided for descrip-
tive purposes only. In the primary repeated measures 
ANCOVA, there were significant main effects of group 
for both frontal (F(1,133) = 4.50, P =  .036) and temporal 
(F(1,133) = 4.40, P =  .038) gray matter volumes such that 
high schizotypy individuals had less volume overall com-
pared with low schizotypy individuals. There were also 
significant group × region interactions for frontal white 
(F(1,133) = 2.40, P = .049) and gray (F(1,133) = 3.89, P = .003) 
matter volume. Post-hoc analysis indicated lower vol-
umes of white matter in the rostral middle frontal cor-
tex (F(1,133) = 3.95, P =  .049), gray matter pars orbitalis 
(F(1,133) = 4.06, P = .046), and gray matter rostral middle 
frontal cortex (F(1,133) = 8.15, P = .005) in high schizotypy 
participants compared with low schizotypy participants. 
No main effects of group were observed for frontal or 
temporal white matter volume. There was a significant 
main effect of group for temporal gray matter thickness 
(F(1,133)  =  4.40, P  =  .038), but not for frontal gray mat-
ter thickness. Specifically, high schizotypy participants 
exhibited lower gray matter thickness compared with 
low schizotypy participants. The group-by-region inter-
actions were not statistically significant for gray matter 
thickness in either the frontal or temporal lobes (P’s > 
.05). The frontal and temporal lobe gray matter thickness 
measures are provided in table 2 with univariate analyses 
provided for descriptive purposes only.
Analysis of FA using the tract-based measures revealed 
a significant main effect of group for the IFOF (F(1,133) 
= 4.90, P = .029) such that high schizotypy individuals 
had lower FA compared with low schizotypy individuals. 
In addition, there was a significant group × hemisphere 
interaction for the UF (F(1,133) = 6.29, 133, P = .013). Post-
hoc analysis revealed that high schizotypy individuals 
had significantly greater asymmetry (R > L; t(136) = −2.78, 
P = .006) in the UF compared with low schizotypy indi-
viduals. There were no significant group differences in FA 
in either the right or left UF. Neither the main effects of 
group nor group-by-hemisphere interactions were sta-
tistically significant for the SLF, ILF, or cingulum bun-
dle. Mean (SD) FA values for the tracts are provided in 
table 3 with univariate analyses provided for descriptive 
purposes only.
To determine whether having both volume and thick-
ness abnormalities was associated with greater psy-
chometric schizotypy, we conducted 3 supplementary 
logistic regression analyses to predict group membership 
for regions that differed significantly between groups 
including gray matter volume (rostral middle frontal and 
pars orbitalis), white matter volume (rostral middle fron-
tal), and average temporal lobe gray matter thickness. 
Classes of regions (gray matter, white matter, and thick-
ness) were entered into the logistic regression in blocks 
to determine whether the overall model improved sig-
nificantly by adding the last block. Thus, as an example, 
in one logistic regression gray matter and white matter 
volumes were entered into the model as the first block 
followed by temporal gray matter thickness in the sec-
ond block to determine whether the addition of the latter 
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variable significantly improved the overall model. None 
of the regression models were significant (P > .05) sug-
gesting that no particular abnormality predicted group 
membership above and beyond the others.
Supplementary ANCOVA were conducted using 3 
groups (low, medium, and high psychometric schizo-
typy) in contrast to the median split approach to further 
examine the relationship between subclinical symptoms 
Table 2. Average Frontal and Temporal Cortical Thickness for Individuals With High and Low Psychometric Schizotypy
Low SPQ 
(N = 71)
High SPQ 
(N = 67)
95% CIa, Low to 
High F PMean (SD) Mean (SD)
Frontal cortical thickness
 Caudal middle frontal 2.62 0.14 2.30 0.13 −0.02 to 0.06 0.87 .35
 Frontal pole 2.89 0.22 2.85 0.22 −0.04 to 0.11 0.99 .32
 Lateral orbitofrontal 2.62 0.12 2.61 0.15 −0.02 to 0.06 0.68 .41
 Medial orbitofrontal 2.36 0.13 2.37 0.12 −0.06 to 0.03 0.49 .49
 Precentral 2.60 0.10 2.56 0.11 −0.003 to 0.06 3.26 .07
 Pars orbitalis 2.83 0.17 2.78 0.17 −0.01 to 0.10 2.78 .10
 Pars opercularis 2.63 0.13 2.61 0.11 −0.03 to 0.04 0.05 .83
 Pars triangularis 2.54 0.13 2.54 0.14 −0.05 to 0.04 0.01 .93
 Rostral middle frontal 2.42 0.12 2.40 0.12 −0.02 to 0.05 0.69 .41
 Superior frontal 2.75 0.13 2.74 0.12 −0.02 to 0.05 0.55 .46
 Paracentral 2.44 0.10 2.41 0.11 −0.01 to 0.06 2.36 .13
Temporal cortical thickness
 Temporal pole 3.81 0.26 3.82 0.26 −0.108 to 0.073 0.14 .71
 Superior temporal 2.83 0.13 2.78 0.12 0.003 to 0.083 4.54 .04
 Middle temporal 2.96 0.13 2.93 0.13 −0.007 to 0.073 2.73 .10
 Inferior temporal 2.88 0.12 2.86 0.13 −0.015 to 0.064 1.52 .22
 Entorhinal 3.68 0.27 3.55 0.28 0.034 to 0.225 7.16 .01
 Parahippocampal 2.76 0.25 2.73 0.27 −0.036 to 0.132 1.29 .26
 Fusiform 2.77 0.12 2.73 0.12 0.004 to 0.077 4.77 .03
 Banks of the superior temporal sulcus 2.54 0.13 2.52 0.12 −0.023 to 0.054 0.63 .43
 Transverse 2.45 0.15 2.42 0.17 −0.029 to 0.075 0.76 .38
Note: df = 138. SPQ, Schizotypal Personality Questionnaire.
aAdjusted for age, sex, and intracranial volume. Analyses are presented for descriptive purposes only.
Table 3. Average Fractional Anisotropy Values for Healthy Individuals With High and Low Psychometric Schizotypy
Low SPQ (N = 71) High SPQ (N = 67)
95% CIa F PMean (SD) Mean (SD)
Fractional anisotropy (FA)
Cingulum
 Left 0.563 0.051 0.557 0.044 −0.015 to 0.015 0.001 .98
 Right 0.533 0.046 0.535 0.050 −0.02 to 0.013 0.16 .69
Inferior fronto-occipital fasciculus
 Left 0.546 0.026 0.536 0.024 0.0003 to 0.015 4.21 .04
 Right 0.542 0.026 0.532 0.024 0.001 to 0.017 4.66 .03
Inferior longitudinal fasciculus
 Left 0.565 0.035 0.557 0.034 −0.006 to 0.017 0.87 .35
 Right 0.552 0.039 0.545 0.031 −0.008 to 0.016 0.46 .50
Superior longitudinal fasciculus
 Left 0.518 0.036 0.513 0.037 −0.01 to 0.015 0.14 .71
 Right 0.521 0.03. 0.520 0.032 −0.012 to 0.01 0.03 .86
Uncinate fasciculus
 Left 0.510 0.0329 0.504 0.032 −0.007 to 0.016 0.58 .45
 Right 0.527 0.0345 0.534 0.032 −0.019 to 0.004 1.75 .19
Note: df = 138. SPQ, Schizotypal Personality Questionnaire.
aAdjusted for age, sex, and intracranial volume. Analyses are presented for descriptive purposes only.
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and our imaging measures; these analyses yielded results 
consistent with our original findings. Moreover, the most 
robust effects were identified between individuals with the 
highest SPQ total scores compared with the other groups. 
Specifically, patients with the highest SPQ total scores 
had significantly (P < .05) lower FA within the IFOF, 
less total gray and white matter in the rostral middle 
frontal gyrus, lower average temporal thickness, and less 
total gray matter in the pars orbitalis compared with the 
other 2 groups. Trend level effects (P = .08) for a group-
×-hemisphere interaction (likely reflecting the lower sta-
tistical power) were evident for asymmetry within the UF 
such that individuals with the highest total SPQ total 
scores demonstrated greater asymmetry compared with 
the other groups.
Although we used sex as a covariate in our analyses, we 
conducted ancillary analyses by removing the 10 young-
est males with low total schizotypy scores from the analy-
sis to better match the groups for sex, which served to 
equate the sex distribution across groups (P = .22) while 
maintaining the age match, and reran all of our primary 
analyses. The group main effects for FA in the IFOF, UF 
FA asymmetry, rostral middle frontal white and gray 
matter volume, and pars orbitalis gray matter volume all 
remained statistically significant (Ps > .05).
Discussion
The results of this investigation indicated an associa-
tion between psychometric schizotypy and measures of 
gray and white matter using both structural and DTI. 
Specifically, our study indicated that otherwise healthy 
adults who exhibit higher levels of psychometric schizo-
typy demonstrated less frontal and temporal lobe gray 
matter and lower temporal lobe gray matter thickness 
compared with participants characterized as lower in 
schizotypy. Regionally specific effects were also evident 
such that individuals characterized as higher in psycho-
metric schizotypy had less gray and white matter vol-
ume specifically within the rostral middle frontal region 
compared with individuals characterized as lower in 
schizotypy. Investigation of cortical thickness measures 
indicated that individuals higher in schizotypy demon-
strated lower temporal (but not frontal) cortical thick-
ness compared with individuals lower in schizotypy. 
Moreover, the use of probabilistic tractography indicated 
that compared with individuals characterized as lower in 
psychometric schizotypy, those who were characterized 
as higher in schizotypy had lower FA in the IFOF as well 
as differences in UF asymmetry. Strengths of the cur-
rent study include the large sample, comprised of healthy 
adults with no history of an Axis I disorder, and no his-
tory of psychotropic medication exposure and the use of 
multimodal imaging measures.
It is difficult to compare our findings to prior work 
given that few studies have investigated psychometric 
schizotypy, especially across a broad range of imaging 
measures. Our findings are generally consistent, how-
ever, with recent data suggesting that high levels of posi-
tive schizotypy in otherwise healthy adults is associated 
with significantly less gray matter volume in medial pre-
frontal, orbitofrontal, and temporal cortical regions.28 
Our findings also converge with prior work in patients 
with SZ54 and SPD,24 which identified less gray matter in 
frontal and temporal lobe regions. Moreover, our study 
identified less gray and white matter that was localized 
to the rostral middle frontal cortex among individuals 
higher in psychometric schizotypy compared with those 
lower in schizotypy. Consistent with our findings, several 
prior neuroimaging studies in SZ reported less gray55 
and white56 matter in the rostral middle frontal region 
and thus, dysfunction involving this region may be par-
ticularly relevant for the overlap in phenotypic expression 
between SZ and schizotypy. It is also noteworthy that 
dysfunction within the rostral middle frontal region may 
contribute to abnormal executive functioning,57 a cogni-
tive domain that is impaired in both SZ58 and SPD.59
Prior work reported that compared with patients with 
SZ, patients with SPD may demonstrate preservation of 
some frontal lobe white matter regions60,61 that could, 
at least in part, reflect a compensatory mechanism. In 
contrast, temporal gray matter abnormalities may be a 
feature shared by both patients with SZ and SPD. This 
hypothesis is consistent with volumetric findings from 
the current study wherein a main effect of group was not 
apparent for frontal lobe white matter volume in con-
trast to the gray matter where a main effect of group was 
observed. This suggests white matter volume at the gross 
anatomic level in the frontal (perhaps except for the ros-
tral middle frontal region) could conceivably be protec-
tive for higher levels of psychometric schizotypy and is 
consistent with the hypothesis that different subregions 
within the frontal cortex may differentiate SZ from SPD. 
In addition, neither global nor regionally specific effects 
were evident between groups in frontal cortical thick-
ness further implicating an additional possible protective 
mechanism from frank psychosis. It should be noted that 
while gray matter volume and cortical thickness share 
similar properties, they are fundamentally different mea-
sures.62,63 For example, although both thickness and area 
can influence volume, volume may be more closely asso-
ciated with surface area than cortical thickness,64 which 
appears to be specifically influenced by cell type and/or 
neuronal density.65
Our finding of lower FA within the IFOF among indi-
viduals higher in psychometric schizotypy is consistent 
with prior work implicating dysfunction of this tract in 
the neurobiology of SZ. For example, Yao et al66 reported 
white matter deficits in first-episode SZ in the left IFOF 
using an activation likelihood estimation meta-analysis 
involving 8 studies that included 271 first-episode patients 
and 297 healthy controls. Moreover, the observation of 
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lower FA within the left IFOF among first-episode neu-
roleptic-naive patients compared with healthy volunteers 
suggests these effects are not an artifact of antipsychotic 
medication exposure.67
There are several limitations to the current study. Our 
use of a self-report instrument to assess schizotypy may 
allow for over or underreporting of positive and nega-
tive subclinical psychotic symptoms. In our larger sample 
comprising 658 participants, however, we found high 
concordance (rho > 0.80) between several measures of 
subclinical psychosis, including the SPQ, and symptoms 
assessed using a clinician administered diagnostic inter-
view (SCID-NP) (P. DeRosse, unpublished data). While 
this does not rule out the possibility of over- or under-
reporting, it lends support to the convergent validity of 
the self-report measure. An additional limitation is that 
because SPQ scores were not normally distributed, we 
utilized a median split to identify high and low schizo-
typy groups. This approach, although maximizing our 
power, may have limited our ability to detect more subtle 
relationships between the level of subclinical psychotic 
symptoms and imaging measures. However, supplemen-
tary analyses comparing 3 groups (high, medium, and low 
SPQ) revealed results nearly identical to those obtained 
using 2 groups. Another potential weakness of the cur-
rent study is the observed sex difference between the high 
and low schizotypy groups. Although we included sex as 
a covariate in our analyses, to ensure that the sex differ-
ence was not driving the result we conducted ancillary 
analyses demonstrating that this did not contribute to 
the observed findings. Finally, it should also be noted 
that tractography measures do not map directly onto the 
brain regions examined using FreeSurfer and thus, we are 
limited in our interpretation across imaging modalities.
In sum, the present study provided evidence for a link 
between psychometric schizotypy and a range of struc-
tural and DTI-derived measures encompassing fronto-
temporal regions in otherwise healthy adults without the 
confound of antipsychotic medications. These findings 
contribute to a growing literature suggesting that psycho-
sis can be examined along a continuum of severity and 
suggest that this continuum may relate to subtle variation 
in brain structure and function. Moreover, results suggest 
that some frontal regions, at least at the gross anatomic 
level, may serve as a compensatory mechanism that may 
be relevant to the distinction between subclinical and 
clinically significant psychotic symptoms.
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